Actualités

Over the last six months, Box’s shares have sunk to $26.48, producing a disappointing 15.3% loss - a stark contrast to the S&P 500’s 10.7% gain. This might have investors contemplating their next move.

Over the last 7 days, the United States market has dropped by 2.5%, yet it has risen by 23% over the past year, with earnings expected to grow by 17% annually in the coming years. In this context of fluctuating performance and anticipated growth, stocks with high insider ownership can be appealing as they often signal confidence from those closest to the company's operations and potential for substantial earnings growth.

Norfolk Southern’s fair value estimate in one analyst model has shifted from US$332.22 to US$335.71 per share, providing an updated reference point for where the stock is being pegged right now. That change sits within a broader split on Wall Street, where some firms are responding to rail volume trends and industrial data with higher targets, while others are trimming their numbers and flagging execution risk. Read on to see what is driving this evolving narrative and how you can keep track...

In recent days, Marathon Petroleum reported first-quarter 2026 earnings that exceeded analyst expectations, driven by strong Refining & Marketing performance and an expanded US$8.60 billion share repurchase authorization. This combination of earnings strength and aggressive buybacks highlights how the company is leaning on cash generation to reshape its capital structure. Next, we’ll examine how Marathon Petroleum’s stronger-than-expected earnings and enlarged buyback program influence its...

Wix stated that it has reduced its revenue expectations by $25 million and expects about a $50 million reduction in bookings for 2026.

Jim Cramer used his June 8, 2026, Squawk on the Street appearance to deliver a direct warning to anyone riding the AI chip rally. His line, after a brutal Friday that saw the Philadelphia semiconductor index post its fourth-worst decline ever: “Unless you have accelerated earnings, your stock is pretty much done. Got to go ... Jim Cramer Warns: AI Stocks Face 50% Crash Without Earnings Growth

ORCL's cloud surge, AI push and $30B U.S. deal set up fiscal Q4, but legacy declines, rising competition and premium valuation cloud the outlook.

Broadcom Inc. (NASDAQ:AVGO) was among the stocks Jim Cramer highlighted on Mad Money as he noted that the market has an appetite for stocks. Cramer highlighted the stock’s parabolic move before the quarter, as he said: … The disappointing earnings may not be as crushing as we think. This is not the first time that […]

LITE raises Q4 FY26 guidance as AI infrastructure demand boosts cloud networking revenues and key optical components remain sold out.

Michael S. Bishop: Thank you, operator. This morning, FuelCell Energy released our financial results for the second quarter of fiscal year 2026 and our earnings press release is available in the Investors section of our website at www.fuelcellenergy.com. In addition to this call and our earnings press release, we have posted a slide presentation on our website.

On this episode of Stock Movers with Alexis Christoforous: - Shares of The Campbell's Company (CPB) edged higher ahead of the US market open after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate. - Eli Lilly (LLY) shares gained in the early session following obesity drug presentations at the American Diabetes Association conference. Citi analysts say their conviction on Lilly is firmly intact, given the company's incretin portfolio is "not built around singular blockbusters." - Shares of Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading as the companies are set to replace Pool Corp. and Campbell's in S&P 500 before the market open on June 22, S&P Dow Jones Indices says in emailed statement.

FuelCell Energy (NASDAQ:FCEL) reported a wider second-quarter loss for fiscal 2026 as a non-cash impairment tied to its Groton Navy project weighed on results, while management emphasized a sharply expanding sales pipeline tied largely to data center and artificial intelligence-related power demand.

Oracle and Adobe headline this week's earnings calendar as investors weigh AI spending, business outlooks and the start of the Q2 reporting cycle.

Adobe (ADBE) heads into its June 11 earnings report with attention fixed on three fronts: CEO succession, competitive pressure in AI driven software, and early read through on Firefly adoption. See our latest analysis for Adobe. Adobe’s share price has been under pressure, with a 1-day share price return of 2.70% decline and a year to date share price return of 24.56% decline. The 1-year total shareholder return is 39.60% lower, reflecting investors reassessing growth prospects and risk...

Oracle stock sinks ahead of Q4 earnings on June 10. Options pricing suggests bearish sentiment on concerns about AI infrastructure capex.

Investors must decide whether Meta's remarkable ad business outweighs its eye-watering AI spending.

The Roundhill Memory ETF (CBOE:DRAM) closed Friday, June 5, 2026 at $55.79, down 15% on the day from a prior close of $65.70. Over the two-day window from June 3 through June 5, the fund dropped 20%, going from $69.71 to that Friday close. If you had $10,000 in DRAM at Wednesday’s open, you had ... Guidance Miss Becomes a Bloodbath: DRAM’s 15% Implosion is At The Center

DOCU tops Q1 fiscal 2027 earnings and revenue estimates as IAM adoption accelerates, profitability improves and ARR growth confidence strengthens.

Oracle stock has bounced back from a steep slump but will face a big test with its fiscal Q4 results due on Wednesday.

FuelCell Energy (FCEL) delivered earnings and revenue surprises of -20.46% and -13.43%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

FuelCell Energy stock has more than doubled in 2026 as the data-center buildout fuels demand for the company’s fuel cell power plants.

Honeywell backed its full-year guidance as it looks to close a spinoff of its aerospace division. The company also on Monday provided an outlook for the remaining company post spinoff, guiding for growth in organic sales and adjusted earnings. Honeywell said it continues to expect full-year sales of $38.8 billion to $39.8 billion, compared with analyst estimates of $39.4 billion, according to FactSet.

Aptiv PLC (NYSE:APTV) is one of the cheap robotics stocks to buy right now. On May 6, UBS reiterated a Buy rating on Aptiv PLC (NYSE:APTV) and an $80 price target, buoyed by the company’s solid first-quarter results. The better-than-expected results came as the company increasingly focuses on enabling devices and systems that sense, think, […]

The wholesale retailer reduced prices on wings, chocolate almonds, golf balls, and king-size sheets by as much as $10

Hewlett Packard Enterprise’s (HPE) first quarter was marked by robust demand across AI, networking, and cloud infrastructure, helping the company deliver results well above Wall Street’s expectations. Management pointed to a surge in orders—outpacing even the strong 40% revenue growth—as evidence of broad customer investment in modernizing IT environments. CEO Antonio Neri highlighted rapid progress integrating Juniper Networks and noted that the combined networking portfolio’s traction, especia

Planet Labs ties defense momentum to an AI push as Q1 FY27 revenues hit a record $94.2M, backlog tops $906M, and full-year sales outlook rises.

LULU cut its 2026 outlook after softer demand, citing negative commentary and weak launches, while accelerating product cycles and global expansion.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at branded pharmaceuticals stocks, starting with Eli Lilly (NYSE:LLY).

Why Modine Manufacturing Stock Is on Investors’ Radar Modine Manufacturing (MOD) has drawn fresh attention after a strong multi year total return and recent gains, prompting investors to reassess how the stock’s current price compares with its fundamentals and intrinsic estimates. See our latest analysis for Modine Manufacturing. After a sharp 1 day share price decline of 8.2% to US$276.51, Modine’s 90 day share price return of 37.52% and very large 5 year total shareholder return suggest...

The updated analyst narrative for West Pharmaceutical Services now reflects a fair value estimate of US$352.36 per share, up from US$349.85. This refinement sits alongside fresh company guidance for Q2 2026 net sales, a recent buyback of 1,222,019 shares for US$297.65 million, and an announced leadership transition planned for the second half of 2026. Read on to see how these moving parts fit together and how you can keep track of the evolving story. Wall Street's queuing for one rocket...